NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCATS E-060-2017-3-PCT-01 Compositions And Methods For Identifying And Treating Dystonia Disorders PCT PCT COMB PCT/US16/054513 Expired
NICHD E-042-2013-0-US-06 Injectable Dendrimer Hydrogel Nanoparticles US CON 15/277,877 11446238 Issued PDF
NHLBI E-124-2014-3-US-01 Device For Closure Of Transvascular Or Transcameral Access Ports US CIP 15/277,798 10058315 Issued PDF
NHLBI E-124-2014-4-US-01 Device For Closure Of Transvascular Or Transcameral Access Ports US CIP 15/277,805 Abandoned
NCI E-111-2014-0-NZ-12 Methods And Compositions For Increasing A T-cell Effector Cell To Regulatory T Cell Ratio NZ National Stage 724722 Abandoned
NIAID E-297-2016-1-US-01 IMPROVED CODON-PAIR-DEOPTIMIZED VACCINE CANDIDATES FOR HUMAN RESPIRATORY SYNCYTIAL VIRUS US 62/400,476 Abandoned
NCI E-054-2017-0-US-01 Methods and Compositions for Treating Non-Hematologic Cancer US 62/400,609 Abandoned
NCI E-062-2019-0-US-01 Method Of Treating Urothelial And Other Genitourinary Carcinomas Using N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N’-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, (2S)-hydroxybutanedioate US 62/400,481 Abandoned
NIAID E-135-2013-0-NZ-06 METHOD FOR SELECTING TICK ANTIGENS AND ANTIGENIC COMPOSITIONS AGAINST TICKS NZ National Stage 721558 Abandoned
NIDDK E-213-2015-0-CN-03 TRIAZOLE DERIVATIVES AS P2Y14 RECEPTOR ANTAGONISTS CN National Stage 201680064441.5 Issued
NCI E-278-2015-1-PCT-02 Human RPN2 Derived Peptides Useful for Treating Cancer PCT PCT PCT/US2016/053352 Abandoned
NIDDK E-213-2015-0-PCT-02 TRIAZOLE DERIVATIVES AS P2Y14 RECEPTOR ANTAGONISTS PCT PCT PCT/US16/053397 Expired
NIAID E-297-2016-0-US-01 Improved Codon-pair-deoptimized Vaccine Candidates For Human Respiratory Syncytial Virus US 62/399,133 Abandoned
NCI E-280-2016-0-US-01 METHODS OF PREPARING AN ISOLATED POPULATION OF DENDRITIC CELLS AND METHODS OF TREATING CANCER USING SAME US 62/398,963 Abandoned
NIA E-013-2010-0-US-10 THE USE OF FENOTEROL AND FENOTEROL ANALOGUES IN THE TREATMENT OF GLIOBLASTOMAS AND ASTROCYTOMAS US CON 15/273,147 10130594 Issued PDF
CC E-088-2014-0-US-03 Conductive and Retrievable Devices US National Stage 15/127,974 Pending
NCATS E-235-2010-0-HK-07 Amido Compounds As RORvt Modulators And Uses Thereof HK EP 16111084.6 Pending
NCI E-258-2016-0-US-01 CHIMERIC ANTIGEN RECEPTOR (CAR) THAT TARGETS CHEMOKINE RECEPTOR CCR4 AND ITS USE US 62/397,810 Abandoned
NCI E-176-2015-1-US-01 METHODS FOR DETECTING EXPRESSION OF LNC-FANCI-2 IN CERVICAL CELLS US ORD 15/270,774 10487365 Issued PDF
NIDDK E-761-2013-0-CN-03 cGAP-PNA Multivalent Peptide Nucleic Acid Ligand Display CN National Stage 201580015122.0 Abandoned
NCI E-264-2015-0-EP-04 MONOCLONAL ANTIBODIES SPECIFIC FOR FIBROBLAST GROWTH FACTOR RECEPTOR 4 (FGFR4)AND METHODS OF THEIR USE EP National Stage 16778536.9 Issued
NCI E-264-2015-0-GB-01 MONOCLONAL ANTIBODIES SPECIFIC FOR FIBROBLAST GROWTH FACTOR RECEPTOR 4 (FGFR4)AND METHODS OF THEIR USE GB EP 16778536.9 Issued
NCI E-264-2015-0-DE-01 MONOCLONAL ANTIBODIES SPECIFIC FOR FIBROBLAST GROWTH FACTOR RECEPTOR 4 (FGFR4)AND METHODS OF THEIR USE DE EP 16778536.9 Issued
NCI E-264-2015-0-FR-01 MONOCLONAL ANTIBODIES SPECIFIC FOR FIBROBLAST GROWTH FACTOR RECEPTOR 4 (FGFR4)AND METHODS OF THEIR USE FR EP 16778536.9 Issued
NCI E-264-2015-0-PCT-02 MONOCLONAL ANTIBODIES SPECIFIC FOR FIBROBLAST GROWTH FACTOR RECEPTOR 4 (FGFR4)AND METHODS OF THEIR USE PCT PCT PCT/US2016/052496 Expired
NCI E-264-2015-0-CA-03 MONOCLONAL ANTIBODIES SPECIFIC FOR FIBROBLAST GROWTH FACTOR RECEPTOR 4 (FGFR4)AND METHODS OF THEIR USE CA National Stage 2996205 Pending
NIAID E-181-2016-0-US-01 ZIKA VIRUS VACCINES US 62/396,613 Abandoned
NCI E-105-2012-0-US-10 MURINE ANTI-NY-ESO-1 T CELL RECEPTORS US CON 15/267,285 10087230 Issued PDF
NIAID E-065-2018-0-CA-05 COMPOSITIONS COMPRISING PREGNANCY SPECIFIC GLYCOPROTEINS AND METHODS OF USE THEREOF CA National Stage 2981191 Pending
NHLBI E-287-2015-0-US-02 Devices And Methods For Effectuating Percutaneous Glenn And Fontan Procedures US ORD 15/267,075 10426482 Issued PDF
NCATS E-020-2016-0-US-07 Antifungal Compound Process US National Stage 15/126,392 10399943 Issued PDF
NCATS E-021-2016-0-US-14 Antifungal Compound Process US National Stage 15/126,402 10173998 Issued PDF
NCATS E-018-2016-0-US-14 Antifungal Compound Process US National Stage 15/126,359 10077250 Issued PDF
NCATS E-023-2016-0-US-07 Antifungal Compound Process US National Stage 15/126,420 10017494 Issued PDF
NCATS E-022-2016-0-US-07 Antifungal Compound Process US National Stage 15/126,412 10000465 Issued PDF
NCATS E-019-2016-0-US-07 Antifungal Compound Process US National Stage 15/126,363 9981943 Issued PDF
NHLBI E-287-2015-2-PCT-01 Devices And Methods For Effectuating Percutaneous Glenn And Fontan Procedures PCT PCT COMB PCT/US2016/052005 Expired
NHGRI E-177-2015-0-PCT-02 CANCER DETECTION METHODS PCT PCT PCT/US2016/051905 Expired
NHLBI E-272-2016-0-US-01 Inhibitors Of FMN2 For Treatment Of Metastatic Melanoma US 62/394,932 Abandoned
NHLBI E-284-2015-0-PCT-02 SEGMENTED MRI CATHETERS AND OTHER INTERVENTIONAL DEVICES PCT PCT PCT/US2016/051600 Expired
NHLBI E-284-2015-0-EP-03 SEGMENTED MRI CATHETERS AND OTHER INTERVENTIONAL DEVICES EP National Stage 16847168.8 Pending
NIAID E-251-2016-0-US-01 METHODS OF DIAGNOSING AND TREATING CD55 DEFICIENCY HYPERACTIVATION OF COMPLEMENT, ANGIOPATHIC THROMBOSIS AND PROTEIN LOSING ENTEROPATHY (CHAPLE), A NEWLY IDENTIFIED ORPHAN DISEASE US 62/394,630 Abandoned
NCI E-269-2015-0-PCT-02 METHODS OF ISOLATING TUMOR-REACTIVE T CELL RECEPTORS FROM TUMOR OR PERIPHERAL BLOOD PCT PCT PCT/US16/051227 Expired
NCI E-265-2015-0-JP-08 T CELL RECEPTORS RECOGNIZING HLA-CW8 RESTRICTED MUTATED KRAS` JP National Stage 2018-513423 Issued
NCI E-265-2015-0-SG-13 T CELL RECEPTORS RECOGNIZING HLA-CW8 RESTRICTED MUTATED KRAS` SG National Stage 11201802069U Issued
NCI E-265-2015-0-SA-12 T CELL RECEPTORS RECOGNIZING HLA-CW8 RESTRICTED MUTATED KRAS` SA National Stage 518391109 Issued
NCI E-265-2015-0-CN-05 T CELL RECEPTORS RECOGNIZING HLA-CW8 RESTRICTED MUTATED KRAS` CN National Stage 201680058891.3 Issued
NCI E-265-2015-0-DK-24 T CELL RECEPTORS RECOGNIZING HLA-CW8 RESTRICTED MUTATED KRAS DK EP 16770408.9 Issued
NCI E-265-2015-0-NL-30 T CELL RECEPTORS RECOGNIZING HLA-CW8 RESTRICTED MUTATED KRAS NL EP 16770408.9 Issued
NCI E-265-2015-0-IE-28 T CELL RECEPTORS RECOGNIZING HLA-CW8 RESTRICTED MUTATED KRAS IE EP 16770408.9 Issued